Dr. Aasems Jacob, MD

Dr. Jacob practices at Piedmont Henry Hospital in Stockbridge, Georgia, part of Piedmont Healthcare.

Dr. Jacob's NPI, 1447633284, was assigned on June 29, 2015. Dr. Jacob holds Kentucky license 51106.

Dr. Jacob's primary practice is Piedmont Henry Hospital, at 1133 Eagle's Landing Parkway, Stockbridge, GA 30281 in Henry County. The practice phone is (678) 604-1000.

Dr. Jacob's primary practice is Piedmont Henry Hospital in Stockbridge, Georgia, part of Piedmont Healthcare. Dr. Jacob is also affiliated with Piedmont Atlanta. The medical group on file is Piedmont Physicians Obstetrics and Gynecology of Jasper. Dmand AI also links Dr. Jacob to 2 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jacob practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Jacob's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Jacob is licensed in Kentucky.

CMS data shows 368 Medicare services from Dr. Jacob across 5 procedure codes in 2024, for 143 Medicare patients. Medicare paid $26,857 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 143 Medicare patients who saw Dr. Jacob in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 33% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jacob's median patient age at 63, with 63% women.

In 2024, Dr. Jacob wrote 1,712 Medicare Part D claims for 201 patients. 77% of them were for generic drugs. CMS names the drug for 1,307 of them, across 45 drugs with 11 or more claims each, at $3,082,066 in total drug cost. In 2023, CMS named 969 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Jacob for performance year 2024, reported as part of a group. Dr. Jacob accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jacob as offering telehealth.

Dmand AI links 49 papers to Dr. Jacob, published from 2012 to 2025. 2022 was the busiest year, with 11. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms and Chemotherapy, Adjuvant. Dr. Jacob has published most often in Cureus. Dr. Jacob's most frequent co-authors are Lakshmi Kannan, MD, Aju Mathew, MD and Aman Chauhan, MD.

CMS Open Payments shows 410 general payments to Dr. Jacob from 52 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 53% of the total. AstraZeneca Pharmaceuticals LP paid the most, $7,697.